from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2716/-

LFCtreatmentdescriptionclass of inhibitor

0.770

Amikacinug/mL Amikacintranslation

1.972

Cap5-10ug/mL Capreomycintranslation

1.062

Rox10-50 ug/mL Roxithromycintranslation

0.236

SM2-5 ug/mL Streptomycintranslation

0.907

Tet5-10 ug/mL Tetracyclinetranslation

-0.214

Rif0.2-5ug/mL Rifampicintranscription

0.143

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.274

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.665

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.642

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.556

Clofazimine10-13 ug/mL Clofaziminerespiration

0.104

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.571

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.314

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.297

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.216

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.040

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.762

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.909

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.324

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.822

KCN5-20 ug/mL Potassium cyaniderespiration

-0.002

NaN30.2-2 mM Sodium aziderespiration

0.841

Nigericin50 uM Nigericinrespiration

-0.710

TRC10-150 ug/mL Triclosanrespiration

-1.231

TRZ10-25 ug/mL Thioridazinerespiration

-0.847

Valinomycin0.5-10 uM Valinomycinrespiration

0.728

ZnSO42 mM ZnSO4respiration

-0.572

menadione6-10 ug/mL Menadionerespiration

-0.468

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.787

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.590

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.102

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.551

NRP_1Non-replicating persistence stage 1dosRassociated

0.347

Amp0.2mg/mL AmpicillincellWall

0.446

Cephalexin20-100 ug/mL CephalexincellWall

0.357

Cerulenin0.32-5 ug/mL CerulenincellWall

0.100

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.155

EMB10-20 ug/mL EthambutolcellWall

-0.197

Eta12-40 ug/mL EthionamidecellWall

-0.295

INH0.2-0.4 ug/mL IsoniazidcellWall

0.292

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.666

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.168

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.158

BZA0.12 mg/mL BenzamidearomaticAmides

0.143

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.096

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.063

H2O24 mM hydrogen peroxideDNAdamaging

-0.164

Levo10 ug/mL LevofloxacinDNAdamaging

0.448

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-3.112

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.008

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.577

UVUV-irradiationDNAdamaging

-1.555

ARP41-4 ug/mL Antitubercular compound ARP4?

0.890

Antimycin12.5-50 ug/mL Antimycin A?

0.733

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.516

PA_110-50 ug/mL Antitubercular compound PA-1?

1.007

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.025

PA8240.2-2 ug/mL PA-824?

-0.709

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.216

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.721

Verapamil50 uM Verapamil?

0.808

mercaptoethanol2 mM 2-Mercaptoethanol?

0.718

methoxatin10-20 ug/mL Methoxatin?